Glargine vs NPH Insulin for Diabetes in Pregnancy
RCT Glargine vs NPH for Treatment of DM in Pregnancy
Recruiting
Phase 3
Interventional Study
Diabetes Mellitus in Pregnancy
Type 2 Diabetes Mellitus (T2DM)
Gestational Diabetes Mellitus, Class A2
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 160 (estimated)
- Sponsor
- Loyola University · Other
Who this trial is looking for
This trial is looking for pregnant individuals with diabetes who need insulin treatment. Participants will compare two types of insulin to see which works better during pregnancy.
Are You a Good Fit for This Trial?
You may be able to join if
- I need insulin therapy for diabetes during my pregnancy.
- I am at least 18 years old.
- I started insulin before 34 weeks of pregnancy.
- I have received prenatal care by 14 weeks of pregnancy.
You may not be able to join if
- I am under 18 years old.
- I cannot consent in English.
- I am allergic to insulin.
- I am managing diabetes with diet or oral medications only.
- I have Type 1 diabetes.
- I am using an insulin pump.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
We are asking you to take part in this research study because you are diagnosed with pregestational Type 2 Diabetes Mellitus or Gestational Diabetes Mellitus requiring insulin therapy in pregnancy. Currently, many hospitals differ among use of insulin for management of DM in pregnancy, with NPH, glargine and detemir being the most commonly used forms of basal insulin. Outside of pregnancy, NPH is …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient requiring initiation of insulin therapy for Gestational Diabetes Mellitus or Type 2 Diabetes Mellitus in pregnancy
* At least 18 years old
* Insulin started prior to 34 weeks gestation
* Established prenatal care by 14 weeks gestation
Exclusion Criteria:
* Those unde…
Contacts